News
Cortado Ventures Reaches First Close of Fund II
First $20M committed in under 6 weeks
Cortado Co-Leads Recuro Health Convertible Note
Recuro Health Announces Convertible Note Financing Co-Led by ARCH Venture Partners & Cortado Ventures: Funds Rapid Expansion of Digital Health Platform.
Cortado Ventures Announces Fund II
Cortado Ventures announces Fund II, aiming for $80M fund to be largest in Oklahoma.
Cortado Ventures Monthly Update: March
Cortado Ventures Monthly Update: March 2022 includes Builder, LP and Team highlights, Cortado funds Senslytics, Cortado in the news, and more
Cortado Funds Senslytics: Predicting the Future with Artificial Intelligence
Senslytics ‘intuition technology’ scales expert insight with AI and machine learning to avert catastrophes and save millions.
Cortado Ventures Monthly Update: February
Builder highlight, Cortado funds Ardley and 19days, portfolio year in review, Cortado in the news, and more
405 Business Magazine Highlights Sensulin
405 Business Magazine published an article this month highlighting Cortado’s funding of biopharmaceutical company Sensulin.
Cortado funds 19days Venture Studio
In February 2022, Gitwit, a digital innovation agency, announced the launch of 19days, a problem-obsessed venture studio. With an inaugural $10MM fund supported by Oklahoma-based venture capital firms Cortado Ventures and Atento Capital, 19days plans to build and launch six business-to-business (B2B) tech ventures in Oklahoma.
Cortado Ventures Monthly Update: January
Year in Review, Builder and LP highlights, Cortado Funds Al Driller and Relativity6, Nathaniel Harding featured on OVF podcast, and more
Cortado Ventures Closes Investment With Exum
Cortado Ventures announces the funding of Denver-based Exum
Cortado Ventures Monthly Update: December
Builder and LP highlights, Cortado funds Access Optics, a win for OKC, Builders + Backers coming to OKC & Tulsa, Governor Stitt kicks off annual meeting, and more
Blog: Oklahoma City biotech investor Cortado Ventures invests in locally founded Sensulin
Home of the Innovation District, University of Oklahoma Health Science Center, and Harold Hamm Diabetes Center is ideal for this homegrown investment
Cortado Ventures Monthly Update: November
Builder and LP highlights, Cortado funds Exum and Dex, Q3 portfolio updates, and more
Article: OLSF Ventures leads $4.5 million investment in Broken Arrow-based Access Optics
Cortado joins Oklahoma Life Science Fund Ventures in recent $4.5 million Series A Preferred investment in Access Optics
Cortado Ventures Monthly Update: October
Builder highlight, Cortado funds Sensulin and Pipedream, VC School Series at 36 Degrees North, Socialwyze presented at the Oklahoma State Legislature and other portfolio company news
CORTADO VENTURES
